携带PBP3插入的大肠埃希菌在全球出现
研究从EnteroBase获取167 518株大肠埃希菌基因组,经质量控制后纳入159 341株,分析青霉素结合蛋白3(PBP3)插入情况。共发现11种PBP3插入变异,占2.01%(n=3198),以YRIN及YRIK重复为主,集中于高风险克隆ST410、ST167和ST405,83.32%编码NDM金属β-内酰胺酶。
要点
- PBP3插入见于2.01%(n=3198)的纳入基因组,以334-337氨基酸重复为主。
- 插入变异集中于高风险克隆ST410(29.18%)、ST167(23.40%)和ST405(10.56%)。
- 83.32%(n=2218)的插入变异菌株编码NDM金属β-内酰胺酶。
核心结论
- 携带PBP3插入、常伴NDMβ-内酰胺酶的大肠埃希菌在高风险ST410、ST167和ST405克隆及多种宿主中全球传播,凸显抗菌药物耐药危机加剧和采取「同一健康」策略的紧迫性。
研究设计与样本
- 从EnteroBase检索167 518株大肠埃希菌基因组,用CheckM2做质量控制,用fastANI确认物种,用多位点序列分型确定序列型(ST),用AMRFinderPlus鉴定耐药基因。
- 用Prokka预测编码序列,用BLAST+比较所得蛋白序列,用SnpEff注释变异,以分析PBP3插入。
主要发现
- 纳入分析的159 341株基因组中,2.01%(n=3198)存在PBP3插入,共11种变异。
- 主要变异为334-337氨基酸(aa)重复,占94.75%(n=3030),包括YRIN(65.92%,n=2108)及其单氨基酸变异YRIK(28.83%,n=922),其次为类似的333-336位PYRI重复(4.16%,n=133)。
- 较少见的为331-334位TIPY重复(n=24)及其单氨基酸变异TYPY重复:TVVPY(n=1)、TVPYTVPY(n=1)和TVPYPVPY(n=1)。
- 罕见重复包括106-109位VGDR(n=3)、114-121位ANALNIPL(n=3)、567-568位AL(n=1)和584-585位TG(n=1)。
- 插入变异在六大洲62个国家检出,主要见于人类样本,涉及85个ST,集中于高风险克隆ST410(29.18%,n=1923)、ST167(23.40%,n=1740)和ST405(10.56%,n=1334),其中83.32%(n=2218)编码金属β-内酰胺酶NDM。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Escherichia coli producing metallo-β-lactamases with penicillin-binding protein 3 (PBP3) insertions have reduced susceptibility to aztreonam-avibactam and cefiderocol. Here, we analysed high-quality E. coli genomes for PBP3 insertions. METHODS: E. coli genomes (n = 167 518) were retrieved from EnteroBase with CheckM2 for quality control, fastANI for species confirmation, multi-locus sequencing typing for sequence type (ST) determination and AMRFinderPlus for resistance gene identification. For PBP3 insertion analysis, we used Prokka for predicting coding sequences, BLAST+ for comparing resulted protein sequences and SnpEff for annotating variants. RESULTS: Among the included 159 341 genomes, PBP3 insertions with 11 variants were found in 2.01% (n = 3198). The predominant variant is a duplication of 334-337 amino acids (aa) (94.75%, n = 3030), comprising YRIN (65.92%, n = 2108) and its single-aa-variant YRIK (28.83%, n = 922), followed by a similar PYRI duplication of 333-336 (4.16%, n = 133). The less common ones are a TIPY duplication of 331-334 (n = 24) and its single-aa-variant TVPY's duplication: TVVPY (n = 1), TVPYTVPY (n = 1) and TVPYPVPY (n = 1). Rare duplications include VGDR of 106-109 (n = 3), ANALNIPL of 114-121 (n = 3), AL of 567-568 (n = 1) and TG of 584-585 (n = 1). Insertion variants were detected across 62 countries on six continents, primarily in human samples, and associated with 85 STs, concentrated in high-risk clones ST410 (29.18%, n = 1923), ST167 (23.40%, n = 1740) and ST405 (10.56%, n = 1334), with 83.32% (n = 2218) encoding metallo-β-lactamase NDM. CONCLUSIONS: Global spread of E. coli harbouring PBP3 insertion, often with NDM β-lactamase, high-risk ST410, ST167 and ST405 clones and various hosts, underscores the escalating antimicrobial resistance crisis and the urgency for a 'One Health' strategy.
引用
- Long H, Zhao F, Feng Y, et al. Global emergence of Escherichia coli with PBP3 insertions. J Antimicrob Chemother. 2025. PMID: 39478333. doi:10.1093/jac/dkae393
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。